Therapeutics announced that it has commenced an underwritten public offering. All shares are being offered by Akebia. Leerink ...
In a report released today, Allison Bratzel from Piper Sandler maintained a Buy rating on Akebia Therapeutics (AKBA – Research Report), with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback